CFDE Data Portal | Search OR51B2

	Label	Description
	OR51B2 associations Collection (Entity type)	Associations for OR51B2_associations
	OR51B2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	OR51B2 Gene (Entity type)	ENSG00000279012 - olfactory receptor family 51 subfamily B member 2
	GSE228106 3 V 2 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE149901 3 V 0 ANLOTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE189859 GSE189861 IDH1 knockout 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 0 V 1 MENADIONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE147626 3 V 1 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

OR51B2 associations

Associations for OR51B2_associations

OR51B2 associations.tsv

A file from IDG as part of the Harmonizome project

OR51B2

ENSG00000279012 - olfactory receptor family 51 subfamily B member 2

GSE228106 3 V 2 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 5 v 2 human dn

A Gene Set from LINCS

GSE149901 3 V 0 ANLOTINIB HUMAN UP

A Gene Set from LINCS

GSE189859 GSE189861 IDH1 knockout 0 v 2 human up

A Gene Set from LINCS

GSE139540 menadione 0 v 1 human dn

A Gene Set from LINCS

GSE139540 0 V 1 MENADIONE HUMAN DN

A Gene Set from LINCS

GSE147626 3 V 1 GLUTATHIONE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.